Submit Deal

Submit Deal

Cover Image Lynn Seely

Lynn Seely

President and CEO at LYELL IMMUNOPHARMA

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 67 M

Avg. Deal Size£ 67 M

Market Context

Sort

24 Oct 2024|United States|Biotechnology

Target: IMMPACT BIO

Bidder: LYELL IMMUNOPHARMA

6 Service Providers

2 Target | 4 Bidder

17 Dealmakers

1 Target | 16 Bidder

£ 67 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite